Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant effect » significant impact (Expand Search)
effect decrease » effects decreased (Expand Search)
decrease costs » increased costs (Expand Search), decreased across (Expand Search)
Showing 141 - 160 results of 42,193 for search '(( significant decrease costs ) OR ( significant effect decrease ))', query time: 1.34s Refine Results
  1. 141
    Description of variables in the mean technical efficiency function.

    Description of variables in the mean technical efficiency function. by James Anaba Akolgo (14129379)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 142
    S1 Data -

    S1 Data - by James Anaba Akolgo (14129379)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 143
    Description of variables used in the production risk function.

    Description of variables used in the production risk function. by James Anaba Akolgo (14129379)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 144
    Distribution of technical efficiency scores of vegetable farmers.

    Distribution of technical efficiency scores of vegetable farmers. by James Anaba Akolgo (14129379)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 145
    Description of inefficiency variables that influence vegetable production.

    Description of inefficiency variables that influence vegetable production. by James Anaba Akolgo (14129379)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 146
    Sample size distribution of dry-season vegetable farmers.

    Sample size distribution of dry-season vegetable farmers. by James Anaba Akolgo (14129379)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 147
    Elasticity and return to scale.

    Elasticity and return to scale. by James Anaba Akolgo (14129379)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 148
    Summary of selected variables in frontier and inefficiency models.

    Summary of selected variables in frontier and inefficiency models. by James Anaba Akolgo (14129379)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 149
    Coverage decrease for spreading processes with the habituation effect.

    Coverage decrease for spreading processes with the habituation effect. by Piotr Bartków (15348211)

    Published 2023
    Save to List
    Saved in:
  10. 150
    CBP per cumulative year for daratumumab and pembrolizumab per vial.

    CBP per cumulative year for daratumumab and pembrolizumab per vial. by R. J. S. D. Heine (17889199)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  11. 151
    S4 Fig -

    S4 Fig - by R. J. S. D. Heine (17889199)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  12. 152
    S1 Fig -

    S1 Fig - by R. J. S. D. Heine (17889199)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  13. 153
    S5 Fig -

    S5 Fig - by R. J. S. D. Heine (17889199)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  14. 154
    S3 Fig -

    S3 Fig - by R. J. S. D. Heine (17889199)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  15. 155
    S6 Fig -

    S6 Fig - by R. J. S. D. Heine (17889199)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  16. 156
    CBP per cumulative indication for daratumumab and pembrolizumab per vial.

    CBP per cumulative indication for daratumumab and pembrolizumab per vial. by R. J. S. D. Heine (17889199)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  17. 157
    Inputs utilized in base-case and scenario analysis for daratumumab and pembrolizumab, both unadjusted and adjusted for PPP and inflation.

    Inputs utilized in base-case and scenario analysis for daratumumab and pembrolizumab, both unadjusted and adjusted for PPP and inflation. by R. J. S. D. Heine (17889199)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  18. 158
    Implementation of indication-based pricing (10<sup>th</sup> scenario) for daratumumab and pembrolizumab.

    Implementation of indication-based pricing (10<sup>th</sup> scenario) for daratumumab and pembrolizumab. by R. J. S. D. Heine (17889199)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  19. 159
    Input parameters for the base-case analysis.

    Input parameters for the base-case analysis. by R. J. S. D. Heine (17889199)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  20. 160
    S2 Fig -

    S2 Fig - by R. J. S. D. Heine (17889199)

    Published 2024
    Subjects:
    Save to List
    Saved in:

Search Tools: